Vaxart Inc (NASDAQ:VXRT) price on Thursday, March 20, fall -2.79% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.57.
A look at the stock’s price movement, the close in the last trading session was $0.58, moving within a range at $0.526 and $0.59. The beta value (5-Year monthly) was 1.696. Turning to its 52-week performance, $1.41 and $0.45 were the 52-week high and 52-week low respectively. Overall, VXRT moved -21.71% over the past month.
Vaxart Inc’s market cap currently stands at around $129.14 million, with investors looking forward to this quarter’s earnings report slated for on 2024-Nov-12.
Analysts have a consensus estimate of 12.4M for the company’s revenue for the quarter, with a low and high estimate of 5.7M and 19.1M respectively. The average forecast suggests up to a 468.55% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 39M, representing a 35.89% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that VXRT is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 1 recommend VXRT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
VXRT’s current price about 8.98% and -13.26% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 49.32, while 7-day volatility ratio is 8.35% and 10.03% in the 30-day chart. Further, Vaxart Inc (VXRT) has a beta value of 1.42, and an average true range (ATR) of 0.05. Analysts have given the company’s stock an average 52-week price target of $2, forecast between a low of $2 and high of $2. Looking at the price targets, the low is -250.88% off current price level while to achieve the yearly target high, price needs to move -250.88%. Nonetheless, investors will most likely welcome a -250.88% jump to $2 which is the analysts’ median price.
If we refocus on Vaxart Inc (NASDAQ:VXRT), historical trading data shows that trading volumes averaged 1.63 over the past 10 days and 1.99 million over the past 3 months. The company’s latest data on shares outstanding shows there are 227.48 million shares.
The 1.02% of Vaxart Inc’s shares are in the hands of company insiders while institutional holders own 22.47% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 13.28 million on 2025-02-28, giving us a short ratio of 7.1. The data shows that as of 2025-02-28 short interest in Vaxart Inc (VXRT) stood at 590.0 of shares outstanding, with shares short rising to 11.11 million registered in 2025-01-31. Current price change has pushed the stock -14.26% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the VXRT stock continues to rise going into the next quarter.
